Nu-Med Plus (NUMD) Debt Ratio (2011 - 2021)

Nu-Med Plus (NUMD) posted Debt Ratio of 0.03 for Q1 2021, up 95.48% sequentially from 0.02 in Q4 2020, and down 98.69% YoY from 2.5 in Q1 2020.

Nu-Med Plus (NUMD) Debt Ratio (2011 - 2021) Analysis & Trends

Nu-Med Plus has reported Debt Ratio for 8 years, with the latest figure at 0.03 in Q1 2021.

Quarterly Debt Ratio fell 98.69% year-over-year to 0.03 in Q1 2021, while the trailing twelve-month figure through Mar 2021 was 0.03 (down 98.69% YoY) and the FY2020 annual result came in at 0.02, down 99.32% from the prior year.
Debt Ratio rose to 0.03 in Q1 2021 per NUMD's latest filing, from 0.02 in the prior quarter.
Over five years, Debt Ratio peaked at 2.5 in Q1 2020 and troughed at 0.02 in Q4 2020.
A 5-year average of 0.37 and a median of 0.05 in 2018 frame the typical range for Debt Ratio.
The sharpest annual moves came in 2019 and 2020: Debt Ratio surged 4715.86% in 2019, then tumbled 99.32% in 2020.
Over 5 years, Debt Ratio stood at 0.05 in 2017, then increased by 5.55% to 0.05 in 2018, then soared by 4715.86% to 2.5 in 2019, then tumbled by 99.32% to 0.02 in 2020, then soared by 95.48% to 0.03 in 2021.
According to Business Quant data, Debt Ratio over the past three periods registered 0.03, 0.02, and 0.19 for Q1 2021, Q4 2020, and Q3 2020 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Abbott Laboratories	199.37 Bn	193.76 Bn	7.27 Bn	0.30
2	Stryker	127.75 Bn	124.27 Bn	4.50 Bn	0.31
3	Medtronic	119.07 Bn	109.85 Bn	6.41 Bn	0.30
4	Boston Scientific	73.39 Bn	72.85 Bn	3.85 Bn	0.28
5	Edwards Lifesciences	51.90 Bn	47.64 Bn	1.35 Bn	0.04
6	Dexcom	34.36 Bn	32.41 Bn	830.00 Mn	-
7	GE HealthCare Technologies	33.90 Bn	31.79 Bn	2.18 Bn	0.27
8	Koninklijke Philips	26.38 Bn	23.06 Bn	4.55 Bn	0.28
9	Steris	23.04 Bn	22.56 Bn	684.20 Mn	0.18
10	Nu-Med Plus	2.03 Mn	2.02 Mn	-	-

Download Data